Ion Beam Applications, SA

Equities

IBAB

BE0003766806

Advanced Medical Equipment & Technology

Market Closed - Euronext Bruxelles Other stock markets 11:35:14 2024-04-24 am EDT			After market 12:05:05 pm
13.3 ^EUR	0.00%		13.28	-0.15%

Mar. 21	Ion Beam Applications SA to Recommend Dividend for 2023	CI
Mar. 21	Transcript : Ion Beam Applications SA, 2023 Earnings Call, Mar 21, 2024

Ion Beam Applications : August 31st, 2021 Executives acquire a 1.16% long term interest in IBA

August 31, 2021 at 01:32 am EDT

Corporate

31.08.2021

Attachments

Original document
Permalink

Disclaimer

IBA - Ion Beam Applications SA published this content on 31 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 31 August 2021 05:31:02 UTC.

Latest news about Ion Beam Applications, SA

Ion Beam Applications SA to Recommend Dividend for 2023	Mar. 21	CI
Transcript : Ion Beam Applications SA, 2023 Earnings Call, Mar 21, 2024	Mar. 21
Ion Beam Applications SA Reports Earnings Results for the Full Year Ended December 30, 2023	Mar. 21	CI
Ion Beam Applications Books Order for Electron Beam Irradiation System	Mar. 19	MT
Ion Signs Contract to Install Be-Efficient Irradiation Solution in Germany	Mar. 19	CI
Ion Beam Applications Bags Cyclotron Order	Feb. 29	MT
Bayer Strikes Supply Deal for Actinium Isotope with Belgian JV	Feb. 13	MT
Ion Beam Applications to Buy US-based Diagnostic X-ray Measurement Company Radcal	Feb. 09	MT
Ion Beam Applications SA signed an agreement to acquire all the assets of Radcal Corporation.	Feb. 07	CI
Ion Beam Applications Sa Announces the Cyclone 70 System Installed At the Ithemba Laboratory for Accelerator Based Sciences in Cape Town	Jan. 23	CI
Ion Beam Applications to Deliver Proton Therapy System to Poland's Health Technologies	Dec. 21	MT
IBA Signs Contract for a ProteusONE Proton Therapy System to be Located at the Greater Poland Cancer Center	Dec. 21	CI
Ion Beam Applications S.A., CMI Inc. and Life Molecular Imaging Announce Japanese Approval for the Reimbursement of Amyloid-Pet Diagnostic Neuraceq in Alzheimer's Disease	Dec. 13	CI
Ion Beam Applications S.A. Announces Start of the Installation of a Cyclone 30 XP in Poland	Dec. 12	CI
Ion Beam Applications Signs Research Partnership with University of Kansas Medical Center	Dec. 05	MT
IBA Signs Research Collaboration Agreement with the University of Kansas Medical Center on Flash Technology	Dec. 05	CI
Ion Beam Applications Receives System Restoration Contract Worth Up to $100 Million	23-10-18	MT
Ion Beam Applications S.A Plans Total System Restoration on its First-Ever Proton Therapy Installation	23-10-18	CI
IBA, Medtechnica Sign Proton Therapy Systems Deal for Medical Center in Israel	23-09-27	MT
Ion Beam Applications S.A. Finalizes Contract with Medtechnica Ltd for Two Proteus®?one Proton Therapy Solutions at the Tel Aviv Sourasky Medical Center in Israel	23-09-27	CI
Ion Beam Applications SA(ENXTBR:IBAB) dropped from S&P Global BMI Index	23-09-18	CI
Transcript : Ion Beam Applications SA, H1 2023 Earnings Call, Aug 31, 2023	23-08-31
Ion Beam Applications SA Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-31	CI
IBA and PARTICLE Initiate Flash Proton Therapy Research Partnership	23-06-15	CI
Ion Beam Applications Books Proton Therapy Equipment Order from CGN Medical Technology	23-06-13	MT

Chart Ion Beam Applications, SA

Duration

Period

More charts

Company Profile

Ion Beam Applications, SA (IBA) specializes in the design, manufacture, and marketing of cancer treatment and diagnosis equipment. Net sales break down by family of products as follows: - diagnosis and therapeutic treatment equipment and systems (85.1%): proton therapy equipment (71.2% of net sales; No. 1 worldwide), and particle accelerators (28.8%) used in the production of radioisotopes (cyclotrons) and in the development of sterilization and ionization solutions (Rhodotron® and Dynamitron®); - equipment and solutions of dosimetry (14.9%; No. 1 worldwide): measurement and analysis tools of the radiation doses in medical imaging and radiation therapy. Net sales are distributed geographically as follows: Belgium (1.2%), the United States (35.3%) and other (63.5%).

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-23 - Q1 2024 Sales and Revenue Release

More about the company

Income Statement Evolution

More financial data

Ratings for Ion Beam Applications, SA

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

13.3 EUR

Average target price

16.17 EUR

Spread / Average Target

+21.55%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
ION BEAM APPLICATIONS, SA	+15.25%	415M
THERMO FISHER SCIENTIFIC	+7.67%	219B
DANAHER CORPORATION	+7.75%	187B
INTUITIVE SURGICAL, INC.	+11.47%	134B
BOSTON SCIENTIFIC CORPORATION	+26.84%	101B
SIEMENS HEALTHINEERS AG	+0.30%	62.27B
EDWARDS LIFESCIENCES CORPORATION	+16.30%	52.82B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-1.63%	47.49B
AGILENT TECHNOLOGIES, INC.	-1.59%	40.79B
GE HEALTHCARE TECHNOLOGIES INC.	+11.95%	39.35B

Other Advanced Medical Equipment & Technology